iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Caplin Steriles receives USFDA approval for two drugs

21 Mar 2023 , 02:33 AM

Lupin announced that its alliance partner has obtained two approvals from the US Food and Drug Administration (USFDA).

The USFDA has granted the final approval to Caplin Steriles, a partner of Lupin, to market its generic version of Zemuron Bromide Injection, 50 mg/5 ml and 100 mg/10 m,l produced by Organon USA Inc. 

Caplin Steriles obtained this approval through its abbreviated new drug application (ANDA) for Rocuronium Bromide Injection, 10mg/ml, which will be available in 5 ml and 10 ml multi-dose vials.

In the United States, Rocuronium Bromide Injection recorded an annual sale of around $53 million.

Furthermore, Lupin’s partner Caplin Steriles has also received the final approval from the FDA for its Thiamine Hydrochloride Injection USP, 200 mg/2 ml (100 mg/ml) in multiple-dose vials. 

This approval allows Caplin Steriles to introduce a therapeutically equivalent version of Fresenius Kabi USA LLC’s Thiamine Hydrochloride Injection USP, 200 mg/2 ml (100mg/ml).

In the United States, sales of Thiamine Hydrochloride Injection USP amounted to roughly $36 million on an annual basis.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • Caplin Steriles
  • Lupin
  • Lupin News
  • Lupin Updates
  • Lupin USFDA
  • Pharma
  • Pharma news
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.